Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • marinevikash
    Junior Member
    • Dec 2010
    • 2

    Help me if u can plz

    What conditions do I use to anneal the adapters and what concentration is optimal for ligation of adapters to the fragmented genomic DNA.
  • ntremblay
    Member
    • Dec 2009
    • 31

    #2
    What kind of experiement are you doing? de novo sequencing, exome capture, etc? you can find these information in a standard protocol ...
    Nicolas Tremblay
    Graduate Student

    Cardiovascular Genetics - Andelfinger Lab
    CHU Ste-Justine Research Center

    Comment

    • marinevikash
      Junior Member
      • Dec 2010
      • 2

      #3
      I mapped the illumina reads (unpaired reads) using Bowtie2. Now i want to extract the uniquely mapped reads. the formate of mapping summary is...

      20000 reads; of these:
      20000 (100.00%) were unpaired; of these:
      1247 (6.24%) aligned 0 times
      18739 (93.69%) aligned exactly 1 time
      14 (0.07%) aligned >1 times
      93.77% overall alignment rate

      So please help me if anyone know that how to extract the uniquely mapped reads..

      Comment

      • dpryan
        Devon Ryan
        • Jul 2011
        • 3478

        #4
        It depends on what metrics you want to use to call something uniquely mapped. It's more useful to think of alignments in terms of probability of being correct, which which case just use something like MAPQ>=10. BTW, bowtie2 will give multimappers MAPQ scores of 0 or 1, but that doesn't mean that alignments with MAPQ scores of 2 are that reliable.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        25 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-23-2026, 11:41 AM
        0 responses
        20 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        27 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        38 views
        0 reactions
        Last Post SEQadmin2  
        Working...